

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * epoxygenase P450 pathway (GO:0019373) | 7.47597987 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.02534872 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.96466365 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.96466365 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.72493915 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.72493915 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.25833389 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.99768890 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95341093 |
| 10 | omega-hydroxylase P450 pathway (GO:0097267) | 5.83251356 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.66926254 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.64290591 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.64290591 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.64290591 |
| 15 | * drug metabolic process (GO:0017144) | 5.58975440 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.54892800 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.52171046 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.31182604 |
| 19 | cysteine metabolic process (GO:0006534) | 5.27685076 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.24390855 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.20093857 |
| 22 | urea cycle (GO:0000050) | 5.19097992 |
| 23 | urea metabolic process (GO:0019627) | 5.19097992 |
| 24 | lysine metabolic process (GO:0006553) | 5.14347714 |
| 25 | lysine catabolic process (GO:0006554) | 5.14347714 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.98615781 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.96257921 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.91208969 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.89548467 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.81087363 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.79565017 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.79265928 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 4.77407448 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.71334317 |
| 35 | bile acid metabolic process (GO:0008206) | 4.70026824 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64480465 |
| 37 | protein carboxylation (GO:0018214) | 4.64480465 |
| 38 | ethanol metabolic process (GO:0006067) | 4.62743582 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.56767494 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.55154894 |
| 41 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.54866193 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.49479765 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.48803063 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.47733228 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.47733228 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.45319861 |
| 47 | regulation of complement activation (GO:0030449) | 4.44407592 |
| 48 | oxidative demethylation (GO:0070989) | 4.43903400 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 4.38774466 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.38168611 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.38168611 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.38168611 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.36207083 |
| 54 | alkaloid metabolic process (GO:0009820) | 4.26057089 |
| 55 | fatty acid beta-oxidation (GO:0006635) | 4.25492743 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.24321269 |
| 57 | hormone catabolic process (GO:0042447) | 4.23098955 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.22293075 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.17650436 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 4.16736206 |
| 61 | phospholipid efflux (GO:0033700) | 4.14379691 |
| 62 | intestinal absorption (GO:0050892) | 4.13495204 |
| 63 | flavonoid metabolic process (GO:0009812) | 4.11579745 |
| 64 | ethanol oxidation (GO:0006069) | 4.10063767 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 4.08728146 |
| 66 | fatty acid oxidation (GO:0019395) | 4.08345709 |
| 67 | negative regulation of sterol transport (GO:0032372) | 4.07570742 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 4.07570742 |
| 69 | 2-oxoglutarate metabolic process (GO:0006103) | 4.06836612 |
| 70 | glutamate metabolic process (GO:0006536) | 4.04489039 |
| 71 | glycine metabolic process (GO:0006544) | 4.03717779 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 4.01686762 |
| 73 | lipid oxidation (GO:0034440) | 4.01626330 |
| 74 | blood coagulation, intrinsic pathway (GO:0007597) | 4.00647204 |
| 75 | cellular modified amino acid catabolic process (GO:0042219) | 3.99773288 |
| 76 | fatty acid catabolic process (GO:0009062) | 3.98474310 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.96251758 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 3.95263360 |
| 79 | cellular glucuronidation (GO:0052695) | 3.94395846 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.92876592 |
| 81 | * phenylpropanoid metabolic process (GO:0009698) | 3.92739454 |
| 82 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.92648509 |
| 83 | drug catabolic process (GO:0042737) | 3.91748997 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.90694635 |
| 85 | organic acid catabolic process (GO:0016054) | 3.89951504 |
| 86 | carboxylic acid catabolic process (GO:0046395) | 3.89951504 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.89844241 |
| 88 | S-adenosylmethionine metabolic process (GO:0046500) | 3.89630822 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.87668539 |
| 90 | amine catabolic process (GO:0009310) | 3.87668539 |
| 91 | ketone body metabolic process (GO:1902224) | 3.87250032 |
| 92 | bile acid and bile salt transport (GO:0015721) | 3.86319683 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.85486273 |
| 94 | cholesterol efflux (GO:0033344) | 3.82238072 |
| 95 | carnitine metabolic process (GO:0009437) | 3.79149024 |
| 96 | phospholipid homeostasis (GO:0055091) | 3.77609273 |
| 97 | angiotensin maturation (GO:0002003) | 3.75906987 |
| 98 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.75368088 |
| 99 | plasma lipoprotein particle assembly (GO:0034377) | 3.74913986 |
| 100 | fructose metabolic process (GO:0006000) | 3.73685941 |
| 101 | valine metabolic process (GO:0006573) | 3.72009829 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.70861740 |
| 103 | arginine metabolic process (GO:0006525) | 3.69638560 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 3.69465527 |
| 105 | drug transmembrane transport (GO:0006855) | 3.64074672 |
| 106 | negative regulation of protein activation cascade (GO:2000258) | 3.62540939 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62236641 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62236641 |
| 109 | negative regulation of lipase activity (GO:0060192) | 3.60886904 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.60781725 |
| 111 | aldehyde catabolic process (GO:0046185) | 3.58674804 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.57328185 |
| 113 | intestinal cholesterol absorption (GO:0030299) | 3.56257489 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 3.53994575 |
| 115 | * cholesterol homeostasis (GO:0042632) | 3.53468170 |
| 116 | branched-chain amino acid catabolic process (GO:0009083) | 3.52788181 |
| 117 | uronic acid metabolic process (GO:0006063) | 3.52583674 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.52583674 |
| 119 | NADH metabolic process (GO:0006734) | 3.52567628 |
| 120 | urate metabolic process (GO:0046415) | 3.51150371 |
| 121 | xenobiotic catabolic process (GO:0042178) | 3.49260591 |
| 122 | protein activation cascade (GO:0072376) | 3.48015359 |
| 123 | primary alcohol metabolic process (GO:0034308) | 3.46556170 |
| 124 | heme transport (GO:0015886) | 3.42650090 |
| 125 | complement activation, classical pathway (GO:0006958) | 3.40380024 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.40168515 |
| 127 | vitamin biosynthetic process (GO:0009110) | 3.37557309 |
| 128 | * xenobiotic metabolic process (GO:0006805) | 3.35671476 |
| 129 | protein-lipid complex assembly (GO:0065005) | 3.30793448 |
| 130 | fibrinolysis (GO:0042730) | 3.30210859 |
| 131 | drug transport (GO:0015893) | 3.27701285 |
| 132 | lipoprotein transport (GO:0042953) | 3.24023926 |
| 133 | complement activation (GO:0006956) | 3.23723335 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 3.20321837 |
| 135 | lipoprotein metabolic process (GO:0042157) | 3.19050949 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 3.14979313 |
| 137 | arginine catabolic process (GO:0006527) | 3.10400477 |
| 138 | negative regulation of complement activation (GO:0045916) | 3.10377310 |
| 139 | L-ascorbic acid metabolic process (GO:0019852) | 3.09456505 |
| 140 | negative regulation of blood coagulation (GO:0030195) | 3.09134765 |
| 141 | negative regulation of hemostasis (GO:1900047) | 3.09134765 |
| 142 | * sterol homeostasis (GO:0055092) | 3.04960113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.97624091 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.92002943 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.62125476 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.28646589 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.24285726 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.06140263 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55514709 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95134530 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51868840 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.98408208 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.28630061 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10759040 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.09361396 |
| 14 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.08505834 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07417930 |
| 16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2931349 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61965743 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.60385171 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58147102 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57207744 |
| 21 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47436476 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41654783 |
| 23 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.35702212 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35379322 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33802737 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29446578 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29235567 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28357677 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.25711402 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24233502 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22002930 |
| 32 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20681315 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18807607 |
| 34 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.17648859 |
| 35 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.16607918 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15296793 |
| 37 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12376804 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11560610 |
| 39 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.11049317 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09600328 |
| 41 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.08688556 |
| 42 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.07331106 |
| 43 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07005531 |
| 44 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06350768 |
| 45 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04664938 |
| 46 | NCOR_22424771_ChIP-Seq_293T_Human | 1.04281923 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02418462 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02418462 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00765530 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00457302 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00273643 |
| 52 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00062782 |
| 53 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99963471 |
| 54 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99888258 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 0.99870209 |
| 56 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.96653510 |
| 57 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95749796 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94501321 |
| 59 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.93658236 |
| 60 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92259228 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91949221 |
| 62 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91499576 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91458610 |
| 64 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91421671 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91035717 |
| 66 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.90561353 |
| 67 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90392904 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90375832 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90080631 |
| 70 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89916418 |
| 71 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89450926 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88516220 |
| 73 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87969830 |
| 74 | NFYB_21822215_ChIP-Seq_K562_Human | 0.87239369 |
| 75 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.86393511 |
| 76 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86250980 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86073884 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86073884 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85948067 |
| 80 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84677176 |
| 81 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.84608314 |
| 82 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.84232710 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83740272 |
| 84 | TBL1_22424771_ChIP-Seq_293T_Human | 0.82380364 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82101556 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81679624 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.81328375 |
| 88 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.81100464 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.80612494 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80603247 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80269289 |
| 92 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.78983950 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.78143038 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77551976 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77179834 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.76876718 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76283472 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.75538030 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74384591 |
| 100 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72325489 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71763734 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71763734 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71223809 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70107990 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69800274 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68539312 |
| 107 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.68009366 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66502501 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65818957 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.64532807 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.64524781 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63925617 |
| 113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63060031 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62360942 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61556444 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.58366699 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.58281928 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.58281928 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57611764 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57168623 |
| 121 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.56620748 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54200107 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53605577 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53472362 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53325395 |
| 126 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52301908 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.51698145 |
| 128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.51055671 |
| 129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.51011191 |
| 130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.50141389 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49846975 |
| 132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49116094 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48939490 |
| 134 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47310480 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46899155 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46386375 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46027250 |
| 138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.45931699 |
| 139 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.45162362 |
| 140 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44826808 |
| 141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43978720 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43801258 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.43778110 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43461222 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43278024 |
| 146 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42223064 |
| 147 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41404426 |
| 148 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41361281 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39183297 |
| 150 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38168392 |
| 151 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37745370 |
| 152 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.37676584 |
| 153 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.37616320 |
| 154 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37182351 |
| 155 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36958817 |
| 156 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36936750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.85753945 |
| 2 | MP0005360_urolithiasis | 7.40598980 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.02358849 |
| 4 | MP0005365_abnormal_bile_salt | 5.90365825 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.72056932 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.95863403 |
| 7 | MP0003252_abnormal_bile_duct | 3.76251922 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61799337 |
| 9 | MP0003195_calcinosis | 3.02920039 |
| 10 | MP0009840_abnormal_foam_cell | 3.00771328 |
| 11 | MP0005332_abnormal_amino_acid | 2.99340990 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.53906008 |
| 13 | MP0005083_abnormal_biliary_tract | 2.53759323 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.28434185 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.24328455 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.23189428 |
| 17 | MP0000609_abnormal_liver_physiology | 2.13469005 |
| 18 | MP0005670_abnormal_white_adipose | 1.92947702 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.88329193 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.86812098 |
| 21 | MP0001764_abnormal_homeostasis | 1.67100436 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65298775 |
| 23 | MP0003183_abnormal_peptide_metabolism | 1.60879559 |
| 24 | MP0003868_abnormal_feces_composition | 1.60868885 |
| 25 | MP0004130_abnormal_muscle_cell | 1.51390747 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.47068389 |
| 27 | MP0003186_abnormal_redox_activity | 1.45054311 |
| 28 | MP0005451_abnormal_body_composition | 1.39900504 |
| 29 | MP0000566_synostosis | 1.35125518 |
| 30 | MP0003879_abnormal_hair_cell | 1.34591255 |
| 31 | MP0009697_abnormal_copulation | 1.33783540 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.31925432 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.27945040 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.26928199 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.25803593 |
| 36 | MP0003011_delayed_dark_adaptation | 1.24845733 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.24102504 |
| 38 | MP0005647_abnormal_sex_gland | 1.19349467 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.15218943 |
| 40 | MP0002971_abnormal_brown_adipose | 1.13086674 |
| 41 | MP0000598_abnormal_liver_morphology | 1.12041441 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.09170602 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 1.07465672 |
| 44 | MP0002254_reproductive_system_inflammat | 1.03450844 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.03240946 |
| 46 | MP0005379_endocrine/exocrine_gland_phen | 0.99577803 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 0.99455935 |
| 48 | MP0002638_abnormal_pupillary_reflex | 0.99361702 |
| 49 | MP0005535_abnormal_body_temperature | 0.97763759 |
| 50 | MP0005334_abnormal_fat_pad | 0.94264413 |
| 51 | MP0009764_decreased_sensitivity_to | 0.93341303 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.93291762 |
| 53 | MP0009763_increased_sensitivity_to | 0.92144902 |
| 54 | MP0000604_amyloidosis | 0.91115166 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 0.89572003 |
| 56 | MP0002132_abnormal_respiratory_system | 0.88535872 |
| 57 | MP0003122_maternal_imprinting | 0.88449429 |
| 58 | MP0009642_abnormal_blood_homeostasis | 0.87095588 |
| 59 | MP0001501_abnormal_sleep_pattern | 0.86347828 |
| 60 | MP0001661_extended_life_span | 0.86115195 |
| 61 | MP0010368_abnormal_lymphatic_system | 0.85792511 |
| 62 | MP0010155_abnormal_intestine_physiology | 0.85273764 |
| 63 | MP0003878_abnormal_ear_physiology | 0.84707183 |
| 64 | MP0005377_hearing/vestibular/ear_phenot | 0.84707183 |
| 65 | MP0001664_abnormal_digestion | 0.84646699 |
| 66 | MP0009379_abnormal_foot_pigmentation | 0.84475606 |
| 67 | MP0001756_abnormal_urination | 0.81221402 |
| 68 | MP0006035_abnormal_mitochondrial_morpho | 0.81141092 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.80235917 |
| 70 | MP0008469_abnormal_protein_level | 0.78165260 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.77932312 |
| 72 | MP0003690_abnormal_glial_cell | 0.77055626 |
| 73 | * MP0005376_homeostasis/metabolism_phenot | 0.76804175 |
| 74 | MP0004043_abnormal_pH_regulation | 0.73436746 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 0.72873617 |
| 76 | MP0003866_abnormal_defecation | 0.71997212 |
| 77 | MP0005448_abnormal_energy_balance | 0.69098845 |
| 78 | MP0002163_abnormal_gland_morphology | 0.68670298 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.67227281 |
| 80 | * MP0005266_abnormal_metabolism | 0.65829111 |
| 81 | MP0009115_abnormal_fat_cell | 0.65328311 |
| 82 | MP0001944_abnormal_pancreas_morphology | 0.65143136 |
| 83 | MP0005375_adipose_tissue_phenotype | 0.64833832 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.64803847 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.64496332 |
| 86 | MP0001984_abnormal_olfaction | 0.63794828 |
| 87 | MP0002938_white_spotting | 0.61648194 |
| 88 | MP0003646_muscle_fatigue | 0.61518069 |
| 89 | MP0000538_abnormal_urinary_bladder | 0.61203894 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.60696046 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 0.60334564 |
| 92 | MP0005330_cardiomyopathy | 0.59094691 |
| 93 | MP0005408_hypopigmentation | 0.58970161 |
| 94 | MP0003329_amyloid_beta_deposits | 0.55915965 |
| 95 | MP0002970_abnormal_white_adipose | 0.54189899 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.52804146 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.52649239 |
| 98 | MP0003953_abnormal_hormone_level | 0.51970440 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.51030665 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.49054704 |
| 101 | MP0002069_abnormal_eating/drinking_beha | 0.48449995 |
| 102 | MP0009053_abnormal_anal_canal | 0.48277001 |
| 103 | * MP0000230_abnormal_systemic_arterial | 0.48053295 |
| 104 | MP0005395_other_phenotype | 0.47753117 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.47080619 |
| 106 | MP0002796_impaired_skin_barrier | 0.46124848 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.45031294 |
| 108 | MP0000678_abnormal_parathyroid_gland | 0.44715420 |
| 109 | MP0002822_catalepsy | 0.44218579 |
| 110 | MP0000477_abnormal_intestine_morphology | 0.43228844 |
| 111 | MP0002168_other_aberrant_phenotype | 0.42897023 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.42312017 |
| 113 | MP0002269_muscular_atrophy | 0.41806949 |
| 114 | MP0004270_analgesia | 0.41429237 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.40568634 |
| 116 | MP0008874_decreased_physiological_sensi | 0.40276602 |
| 117 | MP0006138_congestive_heart_failure | 0.38836254 |
| 118 | MP0004147_increased_porphyrin_level | 0.38293556 |
| 119 | MP0002135_abnormal_kidney_morphology | 0.37873559 |
| 120 | MP0001663_abnormal_digestive_system | 0.37599758 |
| 121 | MP0003959_abnormal_lean_body | 0.37346407 |
| 122 | MP0000013_abnormal_adipose_tissue | 0.37017089 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.36983388 |
| 124 | MP0005646_abnormal_pituitary_gland | 0.36859237 |
| 125 | MP0000462_abnormal_digestive_system | 0.36457987 |
| 126 | MP0003724_increased_susceptibility_to | 0.36387165 |
| 127 | MP0001881_abnormal_mammary_gland | 0.36152251 |
| 128 | MP0001853_heart_inflammation | 0.35957684 |
| 129 | MP0008873_increased_physiological_sensi | 0.35770508 |
| 130 | MP0008872_abnormal_physiological_respon | 0.35496888 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.35083980 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.34491978 |
| 133 | MP0005385_cardiovascular_system_phenoty | 0.34491978 |
| 134 | MP0009672_abnormal_birth_weight | 0.34134551 |
| 135 | MP0002928_abnormal_bile_duct | 0.33628473 |
| 136 | MP0003075_altered_response_to | 0.32596614 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.32482615 |
| 138 | MP0000249_abnormal_blood_vessel | 0.31728985 |
| 139 | MP0003718_maternal_effect | 0.31279031 |
| 140 | MP0003221_abnormal_cardiomyocyte_apopto | 0.30229821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.57025931 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.55215844 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.24326525 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.89071983 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.68904417 |
| 6 | * Xanthomatosis (HP:0000991) | 5.62462559 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.39355013 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.09400233 |
| 9 | Hyperammonemia (HP:0001987) | 4.92815118 |
| 10 | Hyperglycinuria (HP:0003108) | 4.90751452 |
| 11 | Complement deficiency (HP:0004431) | 4.89741635 |
| 12 | Ketosis (HP:0001946) | 4.65690733 |
| 13 | Hyperglycinemia (HP:0002154) | 4.61949496 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.60074285 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.60074285 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.55647324 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46361311 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.40308882 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.21445865 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19915132 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13083375 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.11490765 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.99516114 |
| 24 | Joint hemorrhage (HP:0005261) | 3.92800055 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.85380339 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.79427176 |
| 27 | Abnormality of the common coagulation pathway (HP:0010990) | 3.71034538 |
| 28 | Ketoacidosis (HP:0001993) | 3.70187122 |
| 29 | Fat malabsorption (HP:0002630) | 3.67245253 |
| 30 | * Epidermoid cyst (HP:0200040) | 3.60288711 |
| 31 | Abnormality of complement system (HP:0005339) | 3.49505088 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.35559009 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.33020501 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 3.29785327 |
| 35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.29785327 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 3.25618476 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20401512 |
| 38 | Abnormality of vitamin B metabolism (HP:0004340) | 3.17859823 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.16169228 |
| 40 | Metabolic acidosis (HP:0001942) | 3.10271161 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10250721 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.08039422 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.06101275 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.98865831 |
| 45 | Lethargy (HP:0001254) | 2.95890876 |
| 46 | Gout (HP:0001997) | 2.88741460 |
| 47 | Cerebral edema (HP:0002181) | 2.86567568 |
| 48 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.84025043 |
| 49 | Hyperphosphaturia (HP:0003109) | 2.80944341 |
| 50 | Metabolic alkalosis (HP:0200114) | 2.78981912 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.78979607 |
| 52 | Hyperactive renin-angiotensin system (HP:0000841) | 2.74528009 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.74418990 |
| 54 | Myocardial infarction (HP:0001658) | 2.72512661 |
| 55 | Nephritis (HP:0000123) | 2.64677496 |
| 56 | Steatorrhea (HP:0002570) | 2.63738473 |
| 57 | Hydroxyprolinuria (HP:0003080) | 2.52570185 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.52570185 |
| 59 | Decreased circulating renin level (HP:0003351) | 2.51084326 |
| 60 | Confusion (HP:0001289) | 2.49829125 |
| 61 | Systemic lupus erythematosus (HP:0002725) | 2.47103332 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.45370198 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.45149550 |
| 64 | Vascular calcification (HP:0004934) | 2.42875218 |
| 65 | Vomiting (HP:0002013) | 2.42864461 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.38199862 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.37448724 |
| 68 | Spastic diplegia (HP:0001264) | 2.35945071 |
| 69 | Cholelithiasis (HP:0001081) | 2.35841809 |
| 70 | Spontaneous abortion (HP:0005268) | 2.35157255 |
| 71 | Sensorimotor neuropathy (HP:0007141) | 2.34363573 |
| 72 | Potter facies (HP:0002009) | 2.34349475 |
| 73 | Facial shape deformation (HP:0011334) | 2.34349475 |
| 74 | Abnormal urine phosphate concentration (HP:0012599) | 2.34171507 |
| 75 | Acanthocytosis (HP:0001927) | 2.33356647 |
| 76 | Abnormality of renin-angiotensin system (HP:0000847) | 2.31124562 |
| 77 | Irritability (HP:0000737) | 2.31055820 |
| 78 | Pancreatitis (HP:0001733) | 2.28864133 |
| 79 | Nausea (HP:0002018) | 2.28458115 |
| 80 | Abnormal cartilage morphology (HP:0002763) | 2.28109404 |
| 81 | * Skin nodule (HP:0200036) | 2.27647678 |
| 82 | Myoglobinuria (HP:0002913) | 2.27448251 |
| 83 | Malnutrition (HP:0004395) | 2.26859696 |
| 84 | Neonatal onset (HP:0003623) | 2.26222753 |
| 85 | Cerebral palsy (HP:0100021) | 2.25314378 |
| 86 | Osteomalacia (HP:0002749) | 2.19572371 |
| 87 | Increased purine levels (HP:0004368) | 2.18419374 |
| 88 | Hyperuricemia (HP:0002149) | 2.18419374 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.18157456 |
| 90 | Cholecystitis (HP:0001082) | 2.18157456 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.17693241 |
| 92 | Widely patent fontanelles and sutures (HP:0004492) | 2.17165298 |
| 93 | Late onset (HP:0003584) | 2.17101048 |
| 94 | Renal cortical cysts (HP:0000803) | 2.16928893 |
| 95 | Enlarged kidneys (HP:0000105) | 2.16210570 |
| 96 | Gingival bleeding (HP:0000225) | 2.15781911 |
| 97 | Ileus (HP:0002595) | 2.15557801 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 2.15366347 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15283894 |
| 100 | Brushfield spots (HP:0001088) | 2.13217917 |
| 101 | Poikilocytosis (HP:0004447) | 2.12167654 |
| 102 | Glycosuria (HP:0003076) | 2.10956116 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 2.10956116 |
| 104 | Mitral stenosis (HP:0001718) | 2.03235332 |
| 105 | Hypertriglyceridemia (HP:0002155) | 2.02608160 |
| 106 | Hyperaldosteronism (HP:0000859) | 2.00476013 |
| 107 | Nephrolithiasis (HP:0000787) | 1.99373560 |
| 108 | Megaloblastic anemia (HP:0001889) | 1.99213811 |
| 109 | Hypokalemia (HP:0002900) | 1.98678979 |
| 110 | Esophageal varix (HP:0002040) | 1.98074614 |
| 111 | Amyloidosis (HP:0011034) | 1.96856101 |
| 112 | Hyperglycemia (HP:0003074) | 1.94164807 |
| 113 | Abnormality of the gallbladder (HP:0005264) | 1.91835921 |
| 114 | Abnormality of chloride homeostasis (HP:0011422) | 1.91764427 |
| 115 | Rickets (HP:0002748) | 1.91543377 |
| 116 | Glomerulonephritis (HP:0000099) | 1.91040819 |
| 117 | Hemorrhage of the eye (HP:0011885) | 1.90812653 |
| 118 | Alkalosis (HP:0001948) | 1.90691807 |
| 119 | Rhabdomyolysis (HP:0003201) | 1.85668370 |
| 120 | Elevated hepatic transaminases (HP:0002910) | 1.84925038 |
| 121 | Chronic diarrhea (HP:0002028) | 1.83783641 |
| 122 | Hypothermia (HP:0002045) | 1.83698308 |
| 123 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83340210 |
| 124 | Opisthotonus (HP:0002179) | 1.82523140 |
| 125 | Hepatic necrosis (HP:0002605) | 1.80755551 |
| 126 | Abnormality of vitamin metabolism (HP:0100508) | 1.79503187 |
| 127 | Abnormality of magnesium homeostasis (HP:0004921) | 1.78989241 |
| 128 | Hypomagnesemia (HP:0002917) | 1.77688964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.43574850 |
| 2 | ACVR1B | 4.74450864 |
| 3 | SIK1 | 4.02568554 |
| 4 | ERN1 | 3.63405438 |
| 5 | FGFR4 | 3.62234236 |
| 6 | INSRR | 2.81559835 |
| 7 | TRIB3 | 2.77178443 |
| 8 | MAP3K2 | 2.51305244 |
| 9 | PKN2 | 2.34774639 |
| 10 | ERBB4 | 2.32972912 |
| 11 | MST1R | 2.23760067 |
| 12 | MAP4K2 | 2.20646502 |
| 13 | PDK3 | 2.06563400 |
| 14 | PDK4 | 2.06563400 |
| 15 | NLK | 2.06535479 |
| 16 | LATS1 | 1.85674583 |
| 17 | MAP2K4 | 1.84036916 |
| 18 | TAOK3 | 1.83093548 |
| 19 | GRK1 | 1.79258907 |
| 20 | MAPK11 | 1.75230832 |
| 21 | PINK1 | 1.70117063 |
| 22 | AKT3 | 1.66949343 |
| 23 | FLT3 | 1.65307697 |
| 24 | OXSR1 | 1.62150793 |
| 25 | FRK | 1.57745205 |
| 26 | MAPKAPK3 | 1.56920148 |
| 27 | CAMK1D | 1.55337669 |
| 28 | PIK3CG | 1.55033055 |
| 29 | PRKAA2 | 1.52058909 |
| 30 | STK38L | 1.50572643 |
| 31 | CASK | 1.50538785 |
| 32 | MST4 | 1.49509989 |
| 33 | TNIK | 1.44537255 |
| 34 | MAP3K4 | 1.43590704 |
| 35 | PRKG2 | 1.38997297 |
| 36 | NEK9 | 1.38883901 |
| 37 | NTRK3 | 1.36106621 |
| 38 | STK39 | 1.35255065 |
| 39 | PDK2 | 1.35028857 |
| 40 | PTK6 | 1.27836438 |
| 41 | TNK2 | 1.27828648 |
| 42 | MAP3K7 | 1.24682502 |
| 43 | ABL2 | 1.23551744 |
| 44 | FGFR2 | 1.17882979 |
| 45 | TYK2 | 1.12490637 |
| 46 | LMTK2 | 1.12037317 |
| 47 | TIE1 | 1.11440705 |
| 48 | JAK2 | 1.08098539 |
| 49 | STK24 | 1.03583801 |
| 50 | RIPK1 | 1.03133834 |
| 51 | ADRBK2 | 1.02053649 |
| 52 | KDR | 1.01380913 |
| 53 | PRKAA1 | 1.00088685 |
| 54 | WNK4 | 0.95831169 |
| 55 | NEK1 | 0.95208592 |
| 56 | MYLK | 0.94817876 |
| 57 | DAPK2 | 0.93704300 |
| 58 | MAPK12 | 0.93449917 |
| 59 | CAMKK2 | 0.93164686 |
| 60 | MET | 0.91840539 |
| 61 | MAP2K2 | 0.89746564 |
| 62 | MAP2K3 | 0.87717465 |
| 63 | EPHA2 | 0.86954729 |
| 64 | JAK1 | 0.84676118 |
| 65 | GRK6 | 0.84104176 |
| 66 | BMPR1B | 0.82576852 |
| 67 | MAP3K3 | 0.82518867 |
| 68 | IRAK3 | 0.82392734 |
| 69 | PRKACG | 0.81665193 |
| 70 | CAMK1G | 0.79616870 |
| 71 | PIK3CA | 0.77902875 |
| 72 | CDK6 | 0.76082405 |
| 73 | SGK3 | 0.75685642 |
| 74 | PDPK1 | 0.73785514 |
| 75 | MAPK4 | 0.73768513 |
| 76 | TTN | 0.73670144 |
| 77 | PRKCZ | 0.72978669 |
| 78 | ERBB2 | 0.69665315 |
| 79 | TGFBR2 | 0.68906599 |
| 80 | MAP3K10 | 0.68814577 |
| 81 | EEF2K | 0.68262687 |
| 82 | GSK3A | 0.67226328 |
| 83 | TBK1 | 0.65799267 |
| 84 | PRKCE | 0.65506394 |
| 85 | FGFR3 | 0.63447805 |
| 86 | NUAK1 | 0.62730190 |
| 87 | CAMK2G | 0.61804672 |
| 88 | PHKG1 | 0.60914617 |
| 89 | PHKG2 | 0.60914617 |
| 90 | DMPK | 0.60846432 |
| 91 | OBSCN | 0.60517667 |
| 92 | EPHB1 | 0.59086904 |
| 93 | NME1 | 0.58978499 |
| 94 | KSR2 | 0.58355142 |
| 95 | STK3 | 0.57585093 |
| 96 | MAPK13 | 0.57197937 |
| 97 | CDK19 | 0.56546342 |
| 98 | IRAK1 | 0.55677829 |
| 99 | MAP3K11 | 0.54355161 |
| 100 | SGK2 | 0.54001242 |
| 101 | PRKCG | 0.53998004 |
| 102 | PRKCA | 0.53978991 |
| 103 | MAP2K1 | 0.53426081 |
| 104 | DYRK1B | 0.53144094 |
| 105 | MAPK7 | 0.52719467 |
| 106 | PRKG1 | 0.51063409 |
| 107 | PDK1 | 0.49842385 |
| 108 | SGK494 | 0.49635794 |
| 109 | SGK223 | 0.49635794 |
| 110 | WNK3 | 0.49107148 |
| 111 | PAK3 | 0.47677235 |
| 112 | MAP3K5 | 0.46470843 |
| 113 | MAP3K1 | 0.46170705 |
| 114 | MAP2K6 | 0.44440569 |
| 115 | CSK | 0.44210557 |
| 116 | IGF1R | 0.44197114 |
| 117 | CDK4 | 0.44176150 |
| 118 | PDGFRA | 0.43931324 |
| 119 | TEC | 0.41729675 |
| 120 | MTOR | 0.40796560 |
| 121 | CDC42BPA | 0.40701587 |
| 122 | SGK1 | 0.39973650 |
| 123 | TXK | 0.39293746 |
| 124 | EPHA3 | 0.38968730 |
| 125 | ITK | 0.38768805 |
| 126 | BCR | 0.38251059 |
| 127 | CAMK4 | 0.37898988 |
| 128 | MAPK15 | 0.37797943 |
| 129 | PRKACB | 0.37383952 |
| 130 | LATS2 | 0.37286570 |
| 131 | STK11 | 0.37256320 |
| 132 | CAMK2D | 0.37006693 |
| 133 | PRKCQ | 0.36911530 |
| 134 | RET | 0.36442596 |
| 135 | PTK2 | 0.36392718 |
| 136 | CSNK1A1 | 0.36182568 |
| 137 | MAP3K14 | 0.35675414 |
| 138 | ICK | 0.35343838 |
| 139 | MAP3K6 | 0.35244314 |
| 140 | STK38 | 0.34424062 |
| 141 | PRKD1 | 0.34153298 |
| 142 | PKN1 | 0.28144753 |
| 143 | PRKCH | 0.27645710 |
| 144 | FER | 0.27253981 |
| 145 | EPHA4 | 0.25916346 |
| 146 | PRKACA | 0.24249198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.03779022 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31851688 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19750230 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03384494 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.92947466 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.84200712 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.78813650 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.78236310 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65546406 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60504608 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.52725540 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36775757 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.34652788 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28415392 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24576813 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.21973494 |
| 17 | * Peroxisome_Homo sapiens_hsa04146 | 2.17174750 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.15343796 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10017934 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88491848 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.84488277 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.71725236 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71604858 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71169009 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.68714645 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67780551 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67193670 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67115586 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64692807 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60316264 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51218457 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51133685 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49012178 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.48453721 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47098061 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46994377 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.41954632 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.39429835 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36597841 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36068376 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.34881171 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34034413 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.33196174 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30973504 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28407210 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24107063 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14131015 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.07519612 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07516939 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03426804 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99254598 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98241245 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97374931 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95768774 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93074531 |
| 56 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89401747 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.89006465 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86743512 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86439569 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86430269 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83197909 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.82927269 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81679258 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75276130 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62793644 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51832587 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.49611766 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48030202 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44877415 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41967934 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41454413 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40861587 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38402435 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.34305297 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34192210 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28957380 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28809132 |
| 78 | Prion diseases_Homo sapiens_hsa05020 | 0.23780112 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.23124377 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21662740 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20824579 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.20468008 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19266286 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.17550510 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17382876 |
| 86 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15466163 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10740411 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10130272 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09288505 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08262599 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04750359 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04456787 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02009365 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.01093161 |
| 95 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.2192604 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.2140324 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1823791 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1792577 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1671509 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1659602 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1597028 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1452741 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1440984 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1430579 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.1345250 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1254031 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | -0.1099842 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1095913 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0892996 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0742445 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0679032 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0242581 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0039035 |

